Medigene Dividend

Dividend criteriumcontroles 0/6

Medigene does not have a record of paying a dividend.

Belangrijke informatie

n/a

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendementn/a
Toekomstig dividendrendementn/a
Dividendgroein/a
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeeln/a
Uitbetalingsration/a

Recente dividendupdates

Geen updates

Recent updates

Here's Why We're Watching Medigene's (ETR:MDG1) Cash Burn Situation

Jan 03
Here's Why We're Watching Medigene's (ETR:MDG1) Cash Burn Situation

The Strong Earnings Posted By Medigene (ETR:MDG1) Are A Good Indication Of The Strength Of The Business

Aug 12
The Strong Earnings Posted By Medigene (ETR:MDG1) Are A Good Indication Of The Strength Of The Business

Medigene AG (ETR:MDG1) Analysts Just Trimmed Their Revenue Forecasts By 41%

Aug 10
Medigene AG (ETR:MDG1) Analysts Just Trimmed Their Revenue Forecasts By 41%

We're Hopeful That Medigene (ETR:MDG1) Will Use Its Cash Wisely

Mar 24
We're Hopeful That Medigene (ETR:MDG1) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Medigene's (ETR:MDG1) Cash Burn Situation

Nov 29
Here's Why We're Not Too Worried About Medigene's (ETR:MDG1) Cash Burn Situation

This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medigene AG's (ETR:MDG1) CEO

Jun 17
This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medigene AG's (ETR:MDG1) CEO

We're Keeping An Eye On Medigene's (ETR:MDG1) Cash Burn Rate

Mar 29
We're Keeping An Eye On Medigene's (ETR:MDG1) Cash Burn Rate

How Much Did Medigene's(ETR:MDG1) Shareholders Earn From Share Price Movements Over The Last Three Years?

Feb 16
How Much Did Medigene's(ETR:MDG1) Shareholders Earn From Share Price Movements Over The Last Three Years?

How Much Is Medigene's (ETR:MDG1) CEO Getting Paid?

Dec 23
How Much Is Medigene's (ETR:MDG1) CEO Getting Paid?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Insufficient data to determine if MDG1's dividends per share have been stable in the past.

Groeiend dividend: Insufficient data to determine if MDG1's dividend payments have been increasing.


Dividendrendement versus markt

Medigene Dividendrendement versus markt
Hoe verhoudt MDG1 dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (MDG1)n/a
Markt onderkant 25% (DE)1.6%
Markt Top 25% (DE)4.8%
Gemiddelde industrie (Biotechs)1.5%
Analist prognose (MDG1) (tot 3 jaar)n/a

Opmerkelijk dividend: Unable to evaluate MDG1's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hoog dividend: Unable to evaluate MDG1's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Winstuitkering aan aandeelhouders

Verdiendekking: Insufficient data to calculate MDG1's payout ratio to determine if its dividend payments are covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: Unable to calculate sustainability of dividends as MDG1 has not reported any payouts.


Ontdek bedrijven met een sterk dividend